Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease

International Journal of Clinical Practice

Volumn 62, Issue 1, 2008, Pages 10-17

  Vila Corcoles A ^a   Ochoa, O ^a   De Diego, C ^a   Valdivieso, A ^b   Herreros, I ^a   Bobe F ^a   Alvarez, M ^a   Juarez M ^a   Guinea, I ^a   Ansa, X ^a   Saun N ^a  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b IDIAP Jordi Gol I Gurina ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGED; AGING; ARTICLE; AUTUMN; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY CARE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; GENDER; GROUPS BY AGE; HAZARD RATIO; HEART DISEASE; HUMAN; HYPERTENSION; IMMUNOCOMPROMISED PATIENT; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SMOKING; SPAIN; STATISTICAL ANALYSIS; TREATMENT OUTCOME; WINTER;

AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEASONS; SPAIN;

EID: 37349040012     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01414.x     Document Type: Article

References (30)

1. Lupatkin H. Influenza vaccine in the elderly and chronic obstructive pulmonary disease. Curr Infect Dis Rep 2005 7 : 200 3.
2. WHO. Influenza vaccines. Recommendations for the use of inactivated influenza vaccines and other preventive measures. Wkly Epidemiol Rec 2000 75 : 281 8.
3. Centers for Disease Control and Prevention. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2004 53 (RR 06 1 40.
4. Van Essen GA, Palache AM, Forleo E, Fedson DS. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003 21 : 1780 5.
5. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995 123 : 518 27.
6. Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002 20 : 1831 6.
7. Rivetti D, Jefferson T, Thomas R et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2006 3 : CD004876.
8. Nichol KL. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003 21 : 1769 75.
9. Sprenger MJ, Mulder PG, Beyer WE, van Strik R, Masurel N. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol 1993 22 : 334 40.
10. Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006 1 : CD002733.
11. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998 158 : 1769 76.
12. Voordouw AC, Sturkenboom MC, Dieleman JP et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 2004 292 : 2089 95.
13. Wongsurakiat P, Maranetra KN, Wasi C et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004 125 : 2011 20.
14. Gorse GJ, O'Connor TZ, Newman FK et al. Immunity to influenza in older adults with chronic obstructive pulmonary disease. J Infect Dis 2004 190 : 11 9.
15. Centro Nacional de Epidemiología. Vigilancia centinela de la gripe en España. Temporada 2001-2002. Boletín Epidemiológico Semanal 2002 10 : 149 60.
16. Centro Nacional de Epidemiología. Vigilancia de la gripe en España en la temporada 2002-2003. Sistemas centinela. Boletín Epidemiológico Semanal 2003 11 : 145 56.
17. Centro Nacional de Epidemiología. Vigilancia de la gripe en España en la temporada 2003-2004. Sistemas centinela. Boletín Epidemiológico Semanal 2004 12 : 113 24.
18. Centro Nacional de Epidemiología. Vigilancia de la gripe en España con sistemas centinela. Actividad gripal en la temporada 2004-2005. Boletín Epidemiológico Semanal 2005 13 : 205 16.
19. Hosmer DW, Lemeshow S. Applied Survival Analysis. Regression Modeling of Time to Event Data. New York : John Wiley & Sons, 1999.
20. Govaert TM, Thijs CT, Masurel N et al. The efficacy of influenza vaccination in elderly individuals: a randomized double blind placebo controlled trial. JAMA 1994 272 : 1661 5.
21. Hak E, Nordin J, Wei F et al. Influence of high risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed care organisations. Clin Infect Dis 2002 35 : 370 7.
22. Carrat F, Valleron AJ. Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination? J Epidemiol Community Health 1995 49 : 419 25.
23. Simonsen L, Reichert TA, Viboud C et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005 165 : 265 72.
24. Jimenez-Garcia R, Mayo Montero E, Hernandez Barrera V et al. Evolution of anti-influenza vaccination coverage in Spain from 1993 to 2001. Vaccine 2005 23 : 2844 50.
25. Fukuda K, Cox NJ, Bridges CB, Levandowski RA. Influenza vaccine-inactivated. In : Plotkin SA, Orenstein WA, eds. Vaccines, 4th edn. Philadelphia, PA : Saunders, 2004.
26. WHO. Recommended composition of influenza virus vaccines for use in the 2003 influenza season. Wkly Epidemiol Rec 2002 77 : 341 8.
27. WHO. Influenza in the world. 1 October 2002-30 September 2003. Wkly Epidemiol Rec 2003 78 : 393 6.
28. WHO. Influenza in the world. 1 October 2003-30 September 2004. Wkly Epidemiol Rec 2004 79 : 385 92.
29. WHO. Recommended composition of influenza virus vaccines for use in the 2006 influenza season. Wkly Epidemiol Rec 2005 80 : 342 7.
30. Nichol KL. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003 21 : 1769 75.